2011年1月下旬美国最新医疗新闻.docVIP

Babies delivered by cesarean may be more likely to get bronchiolitis. HYPERLINK /mailview.aspx?m=2011103101amar=1788287-ab90l=02e-01at=c \t _blank Bloomberg News (10/31, Gale) reports, Babies born by elective cesarean section are more likely to get a serious respiratory infection in the first year of life, a study found. Such babies had an 11 percent greater chance of being hospitalized for bronchiolitis, according to a study published in the journal Archives of Disease in Childhood. Vytorin may reduce heart risks in kidney disease patients. HYPERLINK /mailview.aspx?m=2011103101amar=1788287-ab90l=046-35dt=c \t _blank Bloomberg News (10/29, Peterson) reported that the drug Vytorin (ezetimibe and simvastatin) reduces heart risks in patients with kidney disease, according to US regulators weighing whether to approve the expanded use. A clinical trial of the Merck Co. drug showed it reduced the risk of major vascular events by 16 percent, compared with a placebo, Food and Drug Administration staff said in a preliminary HYPERLINK /mailview.aspx?m=2011103101amar=1788287-ab90l=047-daft=c \t _blank review (pdf) posted...on the agencys website. Outside advisers to the FDA are scheduled to meet Nov. 2 to evaluate the findings. Study finds increased cancer risk with bone medication. The HYPERLINK /mailview.aspx?m=2011110401amar=1788287-fb7cl=01e-c18t=c \t _blank New York Times (11/4, Meier, Subscription Publication) reports a Medtronic product, called Infuse, when used in high doses during spinal fusion procedures, might increase patient cancer risks, according to data released Thursday at a national conference of spine surgeons. HYPERLINK /mailview.aspx?m=2011110401amar=1788287-fb7cl=01f-174t=c \t _blank Milwaukee (WI) Journal Sentinel (11/4, Fauber) reports that in an analysis led by Eugene Carragee, a Stanford University orthopedic surgeon, found spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more l